Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Genetic risk factors associated with respiratory distress syndrome

  • Jo, Heui Seung (Department of Pediatrics, CHA Bundang Medical Center, CHA University)
  • Received : 2013.09.15
  • Accepted : 2014.03.14
  • Published : 2014.04.15
Download PDF
⟨ Previous Next ⟩

Abstract

Respiratory distress syndrome (RDS) among preterm infants is typically due to a quantitative deficiency of pulmonary surfactant. Aside from the degree of prematurity, diverse environmental and genetic factors can affect the development of RDS. The variance of the risk of RDS in various races/ethnicities or monozygotic/dizygotic twins has suggested genetic influences on this disorder. So far, several specific mutations in genes encoding surfactant-associated molecules have confirmed this. Specific genetic variants contributing to the regulation of pulmonary development, its structure and function, or the inflammatory response could be candidate risk factors for the development of RDS. This review summarizes the background that suggests the genetic predisposition of RDS, the identified mutations, and candidate genetic polymorphisms of pulmonary surfactant proteins associated with RDS.

Keywords

References

  1. Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. AMA J Dis Child 1959;97(5 Part 1): 517-23.
  2. Hallman M, Marttila R, Pertile R, Ojaniemi M, Haataja R. Genes and environment in common neonatal lung disease. Neonatology 2007;91:298-302. https://doi.org/10.1159/000101345
  3. Farrell PM, Wood RE. Epidemiology of hyaline membrane disease in the United States: analysis of national mortality statistics. Pediatrics 1976;58:167-76.
  4. Bryan H, Hawrylyshyn P, Hogg-Johnson S, Inwood S, Finley A, D'Costa M, et al. Perinatal factors associated with the respiratory distress syndrome. Am J Obstet Gynecol 1990;162:476-81. https://doi.org/10.1016/0002-9378(90)90415-4
  5. Fujikura T, Froehlich LA. The influence of race and other factors on pulmonary hyaline membranes: a report from the Collaborative Study of Cerebral Palsy. Am J Obstet Gynecol 1966;95:572-8. https://doi.org/10.1016/0002-9378(66)90153-0
  6. Nagourney BA, Kramer MS, Klebanoff MA, Usher RH. Recurrent respiratory distress syndrome in successive preterm pregnancies. J Pediatr 1996;129:591-6. https://doi.org/10.1016/S0022-3476(96)70125-7
  7. Reed DM, Bakketeig LS, Nugent RP. The epidemiology of respiratory distress syndrome in Norway. Am J Epidemiol 1978;107:299-310. https://doi.org/10.1093/oxfordjournals.aje.a112545
  8. Nogee LM, de Mello DE, Dehner LP, Colten HR. Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med 1993;328:406-10. https://doi.org/10.1056/NEJM199302113280606
  9. Nogee LM, Dunbar AE 3rd, Wert SE, Askin F, Hamvas A, Whitsett JA. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001;344:573-9. https://doi.org/10.1056/NEJM200102223440805
  10. Shulenin S, Nogee LM, Annilo T, Wert SE, Whitsett JA, Dean M. ABCA3 gene mutations in newborns with fatal surfactant deficiency. N Engl J Med 2004;350:1296-303. https://doi.org/10.1056/NEJMoa032178
  11. Wert SE, Whitsett JA, Nogee LM. Genetic disorders of surfactant dysfunction. Pediatr Dev Pathol 2009;12:253-74. https://doi.org/10.2350/09-01-0586.1
  12. Silveyra P, Floros J. Genetic variant associations of human SP- A and SP-D with acute and chronic lung injury. Front Biosci (Landmark Ed) 2012;17:407-29. https://doi.org/10.2741/3935
  13. Hallman M, Haataja R. Surfactant protein polymorphisms and neonatal lung disease. Semin Perinatol 2006;30:350-61. https://doi.org/10.1053/j.semperi.2006.09.002
  14. Ross S, Naeye RL. Racial and environmental influences on fetal lung maturation. Pediatrics 1981;68:790-5.
  15. Hulsey TC, Alexander GR, Robillard PY, Annibale DJ, Keenan A. Hyaline membrane disease: the role of ethnicity and maternal risk characteristics. Am J Obstet Gynecol 1993;168:572-6. https://doi.org/10.1016/0002-9378(93)90496-6
  16. Kavvadia V, Greenough A, Dimitriou G, Hooper R. Influence of ethnic origin on respiratory distress syndrome in very premature infants. Arch Dis Child Fetal Neonatal Ed 1998;78:F25-8. https://doi.org/10.1136/fn.78.1.F25
  17. Anadkat JS, Kuzniewicz MW, Chaudhari BP, Cole FS, Hamvas A. Increased risk for respiratory distress among white, male, late preterm and term infants. J Perinatol 2012;32:780-5. https://doi.org/10.1038/jp.2011.191
  18. Olowe SA, Akinkugbe A. Amniotic fluid lecithin/sphingomyelin ratio: comparison between an African and North American community. Pediatrics 1978;62:38-41.
  19. Effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome. Am J Obstet Gynecol 1981; 141:276-87. https://doi.org/10.1016/S0002-9378(16)32633-3
  20. Richardson DK, Torday JS. Racial differences in predictive value of the lecithin/sphingomyelin ratio. Am J Obstet Gynecol 1994;170(5 Pt 1):1273-8. https://doi.org/10.1016/S0002-9378(94)70141-5
  21. Leth-Larsen R, Garred P, Jensenius H, Meschi J, Hartshorn K, Madsen J, et al. A common polymorphism in the SFTPD gene influences assembly, function, and concentration of surfactant protein D. J Immunol 2005;174:1532-8. https://doi.org/10.4049/jimmunol.174.3.1532
  22. Cole FS, Hamvas A, Nogee LM. Genetic disorders of neonatal respiratory function. Pediatr Res 2001;50:157-62. https://doi.org/10.1203/00006450-200108000-00001
  23. Hamvas A, Cole FS, Nogee LM. Genetic disorders of surfactant proteins. Neonatology 2007;91:311-7. https://doi.org/10.1159/000101347
  24. van Sonderen L, Halsema EF, Spiering EJ, Koppe JG. Genetic influences in respiratory distress syndrome: a twin study. Semin Perinatol 2002;26:447-9. https://doi.org/10.1053/sper.2002.37315
  25. Marttila R, Haataja R, Ramet M, Lofgren J, Hallman M. Surfactant protein B polymorphism and respiratory distress syndrome in premature twins. Hum Genet 2003;112:18-23. https://doi.org/10.1007/s00439-002-0835-y
  26. Pilot-Matias TJ, Kister SE, Fox JL, Kropp K, Glasser SW, Whitsett JA. Structure and organization of the gene encoding human pulmonary surfactant proteolipid SP-B. DNA 1989;8:75-86. https://doi.org/10.1089/dna.1.1989.8.75
  27. Johansson J. Structure and properties of surfactant protein C. Biochim Biophys Acta 1998;1408:161-72. https://doi.org/10.1016/S0925-4439(98)00065-9
  28. Nogee LM. Genetics of the hydrophobic surfactant proteins. Biochim Biophys Acta 1998;1408:323-33. https://doi.org/10.1016/S0925-4439(98)00078-7
  29. Brasch F, Schimanski S, Muhlfeld C, Barlage S, Langmann T, Aslanidis C, et al. Alteration of the pulmonary surfactant system in full-term infants with hereditary ABCA3 deficiency. Am J Respir Crit Care Med 2006;174:571-80. https://doi.org/10.1164/rccm.200509-1535OC
  30. Nogee LM. Surfactant protein-B deficiency. Chest 1997;111(6 Suppl): 129S-135S.
  31. Hamvas A, Trusgnich M, Brice H, Baumgartner J, Hong Y, Nogee LM, et al. Population-based screening for rare mutations: highthroughput DNA extraction and molecular amplification from Guthrie cards. Pediatr Res 2001;50:666-8. https://doi.org/10.1203/00006450-200111000-00021
  32. Nogee LM, Garnier G, Dietz HC, Singer L, Murphy AM, deMello DE, et al. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 1994;93:1860-3. https://doi.org/10.1172/JCI117173
  33. Hamvas A, Nogee LM, Mallory GB Jr, Spray TL, Huddleston CB, August A, et al. Lung transplantation for treatment of infants with surfactant protein B deficiency. J Pediatr 1997;130:231-9. https://doi.org/10.1016/S0022-3476(97)70348-2
  34. Garmany TH, Wambach JA, Heins HB, Watkins-Torry JM, Wegner DJ, Bennet K, et al. Population and disease-based prevalence of the common mutations associated with surfactant deficiency. Pediatr Res 2008;63:645-9. https://doi.org/10.1203/PDR.0b013e31816fdbeb
  35. Nogee LM, Wert SE, Proffit SA, Hull WM, Whitsett JA. Allelic heterogeneity in hereditary surfactant protein B (SP-B) deficiency. Am J Respir Crit Care Med 2000;161(3 Pt 1):973-81. https://doi.org/10.1164/ajrccm.161.3.9903153
  36. Hamvas A. Current technology in the diagnosis of developmentally related lung disorders. Neonatology 2012;101:353-9. https://doi.org/10.1159/000337356
  37. Tredano M, Griese M, de Blic J, Lorant T, Houdayer C, Schumacher S, et al. Analysis of 40 sporadic or familial neonatal and pediatric cases with severe unexplained respiratory distress: relationship to SFTPB. Am J Med Genet A 2003;119A:324-39. https://doi.org/10.1002/ajmg.a.20058
  38. Dunbar AE 3rd, Wert SE, Ikegami M, Whitsett JA, Hamvas A, White FV, et al. Prolonged survival in hereditary surfactant protein B (SPB) deficiency associated with a novel splicing mutation. Pediatr Res 2000;48:275-82. https://doi.org/10.1203/00006450-200009000-00003
  39. Klein JM, Thompson MW, Snyder JM, George TN, Whitsett JA, Bell EF, et al. Transient surfactant protein B deficiency in a term infant with severe respiratory failure. J Pediatr 1998;132:244-8. https://doi.org/10.1016/S0022-3476(98)70439-1
  40. Whitsett JA, Weaver TE. Hydrophobic surfactant proteins in lung function and disease. N Engl J Med 2002;347:2141-8. https://doi.org/10.1056/NEJMra022387
  41. Nerelius C, Martin E, Peng S, Gustafsson M, Nordling K, Weaver T, et al. Mutations linked to interstitial lung disease can abrogate anti-amyloid function of prosurfactant protein C. Biochem J 2008; 416:201-9. https://doi.org/10.1042/BJ20080981
  42. Thomas AQ, Lane K, Phillips J 3rd, Prince M, Markin C, Speer M, et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 2002;165:1322-8. https://doi.org/10.1164/rccm.200112-123OC
  43. Cameron HS, Somaschini M, Carrera P, Hamvas A, Whitsett JA, Wert SE, et al. A common mutation in the surfactant protein C gene associated with lung disease. J Pediatr 2005;146:370-5. https://doi.org/10.1016/j.jpeds.2004.10.028
  44. Kropski JA, Lawson WE, Young LR, Blackwell TS. Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis. Dis Model Mech 2013;6:9-17. https://doi.org/10.1242/dmm.010736
  45. Soraisham AS, Tierney AJ, Amin HJ. Neonatal respiratory failure associated with mutation in the surfactant protein C gene. J Perinatol 2006;26:67-70. https://doi.org/10.1038/sj.jp.7211417
  46. Bullard JE, Wert SE, Whitsett JA, Dean M, Nogee LM. ABCA3 mutations associated with pediatric interstitial lung disease. Am J Respir Crit Care Med 2005;172:1026-31. https://doi.org/10.1164/rccm.200503-504OC
  47. Doan ML, Guillerman RP, Dishop MK, Nogee LM, Langston C, Mallory GB, et al. Clinical, radiological and pathological features of ABCA3 mutations in children. Thorax 2008;63:366-73. https://doi.org/10.1136/thx.2007.083766
  48. Boggaram V. Thyroid transcription factor-1 (TTF-1/Nkx2.1/TITF1) gene regulation in the lung. Clin Sci (Lond) 2009;116:27-35. https://doi.org/10.1042/CS20080068
  49. Whitsett JA, Wert SE, Trapnell BC. Genetic disorders influencing lung formation and function at birth. Hum Mol Genet 2004;13 Spec No 2:R207-15. https://doi.org/10.1093/hmg/ddh252
  50. Martis PC, Whitsett JA, Xu Y, Perl AK, Wan H, Ikegami M. C/ EBPalpha is required for lung maturation at birth. Development 2006;133:1155-64. https://doi.org/10.1242/dev.02273
  51. Wan H, Dingle S, Xu Y, Besnard V, Kaestner KH, Ang SL, et al. Compensatory roles of Foxa1 and Foxa2 during lung morphogenesis. J Biol Chem 2005;280:13809-16. https://doi.org/10.1074/jbc.M414122200
  52. Iwatani N, Mabe H, Devriendt K, Kodama M, Miike T. Deletion of NKX2.1 gene encoding thyroid transcription factor-1 in two siblings with hypothyroidism and respiratory failure. J Pediatr 2000;137:272-6. https://doi.org/10.1067/mpd.2000.107111
  53. Chung C, Kim T, Kim M, Kim M, Song H, Kim TS, et al. Hippo-Foxa2 signaling pathway plays a role in peripheral lung maturation and surfactant homeostasis. Proc Natl Acad Sci U S A 2013;110:7732-7. https://doi.org/10.1073/pnas.1220603110
  54. Kikkawa Y. Morphology of alveolar lining layer. Anat Rec 1970;167:389-400. https://doi.org/10.1002/ar.1091670403
  55. deMello DE, Chi EY, Doo E, Lagunoff D. Absence of tubular myelin in lungs of infants dying with hyaline membrane disease. Am J Pathol 1987;127:131-9.
  56. deMello DE, Phelps DS, Patel G, Floros J, Lagunoff D. Expression of the 35kDa and low molecular weight surfactant-associated proteins in the lungs of infants dying with respiratory distress syndrome. Am J Pathol 1989;134:1285-93.
  57. Eguchi H, Koyama N, Tanaka T, Kamiya K, Ogawa Y. Surfactant apoprotein A (SP-A) in tracheal aspirates of newborn infants with RDS. Acta Paediatr Jpn 1991;33:649-54. https://doi.org/10.1111/j.1442-200X.1991.tb01880.x
  58. Stevens PA, Schadow B, Bartholain S, Segerer H, Obladen M. Surfactant protein A in the course of respiratory distress syndrome. Eur J Pediatr 1992;151:596-600. https://doi.org/10.1007/BF01957730
  59. Cho K, Matsuda T, Okajima S, Matsumoto Y, Sagawa T, Fujimoto S, et al. Prediction of respiratory distress syndrome by the level of pulmonary surfactant protein A in cord blood sera. Biol Neonate 2000;77:83-7. https://doi.org/10.1159/000014198
  60. Kaneko K, Shimizu H, Arakawa H, Ogawa Y. Pulmonary surfactant protein A in sera for assessing neonatal lung maturation. Early Hum Dev 2001;62:11-21. https://doi.org/10.1016/S0378-3782(00)00133-X
  61. Crouch E, Wright JR. Surfactant proteins a and d and pulmonary host defense. Annu Rev Physiol 2001;63:521-54. https://doi.org/10.1146/annurev.physiol.63.1.521
  62. Hawgood S, Poulain FR. The pulmonary collectins and surfactant metabolism. Annu Rev Physiol 2001;63:495-519. https://doi.org/10.1146/annurev.physiol.63.1.495
  63. Wang G, Guo X, Diangelo S, Thomas NJ, Floros J. Humanized SFTPA1 and SFTPA2 transgenic mice reveal functional divergence of SP-A1 and SP-A2: formation of tubular myelin in vivo requires both gene products. J Biol Chem 2010;285:11998-2010. https://doi.org/10.1074/jbc.M109.046243
  64. Hoover RR, Floros J. Organization of the human SP-A and SP-D loci at 10q22-q23. Physical and radiation hybrid mapping reveal gene order and orientation. Am J Respir Cell Mol Biol 1998;18:353-62. https://doi.org/10.1165/ajrcmb.18.3.3035
  65. Krizkova L, Sakthivel R, Olowe SA, Rogan PK, Floros J. Human SP-A: genotype and single-strand conformation polymorphism analysis. Am J Physiol 1994;266(5 Pt 1):L519-27.
  66. Floros J, DiAngelo S, Koptides M, Karinch AM, Rogan PK, Nielsen H, et al. Human SP-A locus: allele frequencies and linkage disequilibrium between the two surfactant protein A genes. Am J Respir Cell Mol Biol 1996;15:489-98. https://doi.org/10.1165/ajrcmb.15.4.8879183
  67. DiAngelo S, Lin Z, Wang G, Phillips S, Ramet M, Luo J, et al. Novel, non-radioactive, simple and multiplex PCR-cRFLP methods for genotyping human SP-A and SP-D marker alleles. Dis Markers 1999;15:269-81. https://doi.org/10.1155/1999/961430
  68. Ramet M, Haataja R, Marttila R, Floros J, Hallman M. Association between the surfactant protein A (SP-A) gene locus and respiratorydistress syndrome in the Finnish population. Am J Hum Genet 2000;66:1569-79. https://doi.org/10.1086/302906
  69. Haataja R, Ramet M, Marttila R, Hallman M. Surfactant proteins A and B as interactive genetic determinants of neonatal respiratory distress syndrome. Hum Mol Genet 2000;9:2751-60. https://doi.org/10.1093/hmg/9.18.2751
  70. Floros J, Fan R, Matthews A, DiAngelo S, Luo J, Nielsen H, et al. Family-based transmission disequilibrium test (TDT) and casecontrol association studies reveal surfactant protein A (SP-A) susceptibility alleles for respiratory distress syndrome (RDS) and possible race differences. Clin Genet 2001;60:178-87.
  71. Jo HS, Cho SI, Chang YH, Kim BI, Choi JH. Surfactant protein A associated with respiratory distress syndrome in Korean preterm infants: evidence of ethnic difference. Neonatology 2013;103:44-7. https://doi.org/10.1159/000342498
  72. Marttila R, Haataja R, Ramet M, Pokela ML, Tammela O, Hallman M. Surfactant protein A gene locus and respiratory distress syndrome in Finnish premature twin pairs. Ann Med 2003;35:344-52. https://doi.org/10.1080/07853890310006389
  73. Thomas NJ, Fan R, Diangelo S, Hess JC, Floros J. Haplotypes of the surfactant protein genes A and D as susceptibility factors for the development of respiratory distress syndrome. Acta Paediatr 2007;96:985-9. https://doi.org/10.1111/j.1651-2227.2007.00319.x
  74. Lee KS, Kim YH, Suk JS, Ko JH, Yoo OJ, Lee IK, et al. Allele distribution and frequency of human surfactant protein-A1 in Korean neonates. J Korean Pediatr Soc 2002;45:1497-502.
  75. Kim NC, Yoon HC, Suk JS, Ko JH, Yoo OJ, Lee IK, et al. Allele distribution and frequency of human surfactant protein-A2 in Korean neonates. J Korean Pediatr Soc 2003;46:340-4.
  76. Whitsett JA, Nogee LM, Weaver TE, Horowitz AD. Human surfactant protein B: structure, function, regulation, and genetic disease. Physiol Rev 1995;75:749-57. https://doi.org/10.1152/physrev.1995.75.4.749
  77. Melton KR, Nesslein LL, Ikegami M, Tichelaar JW, Clark JC, Whitsett JA, et al. SP-B deficiency causes respiratory failure in adult mice. Am J Physiol Lung Cell Mol Physiol 2003;285:L543-9. https://doi.org/10.1152/ajplung.00011.2003
  78. Merrill JD, Ballard RA, Cnaan A, Hibbs AM, Godinez RI, Godinez MH, et al. Dysfunction of pulmonary surfactant in chronically ventilated premature infants. Pediatr Res 2004;56:918-26. https://doi.org/10.1203/01.PDR.0000145565.45490.D9
  79. Floros J, Veletza SV, Kotikalapudi P, Krizkova L, Karinch AM, Friedman C, et al. Dinucleotide repeats in the human surfactant protein-B gene and respiratory-distress syndrome. Biochem J 1995;305 ( Pt 2):583-90. https://doi.org/10.1042/bj3050583
  80. Hamvas A, Wegner DJ, Carlson CS, Bergmann KR, Trusgnich MA, Fulton L, et al. Comprehensive genetic variant discovery in the surfactant protein B gene. Pediatr Res 2007;62:170-5. https://doi.org/10.1203/PDR.0b013e3180a03232
  81. Marttila R, Haataja R, Guttentag S, Hallman M. Surfactant protein A and B genetic variants in respiratory distress syndrome in singletons and twins. Am J Respir Crit Care Med 2003;168:1216-22. https://doi.org/10.1164/rccm.200304-524OC
  82. Lahti M, Marttila R, Hallman M. Surfactant protein C gene variation in the Finnish population - association with perinatal respiratory disease. Eur J Hum Genet 2004;12:312-20. https://doi.org/10.1038/sj.ejhg.5201137
  83. Sorensen GL, Husby S, Holmskov U. Surfactant protein A and surfactant protein D variation in pulmonary disease. Immunobiology 2007;212:381-416. https://doi.org/10.1016/j.imbio.2007.01.003
  84. Hilgendorff A, Heidinger K, Bohnert A, Kleinsteiber A, Konig IR, Ziegler A, et al. Association of polymorphisms in the human surfactant protein-D (SFTPD) gene and postnatal pulmonary adaptation in the preterm infant. Acta Paediatr 2009;98:112-7. https://doi.org/10.1111/j.1651-2227.2008.01014.x
  85. Tredano M, van Elburg RM, Kaspers AG, Zimmermann LJ, Houdayer C, Aymard P, et al. Compound SFTPB 1549C-- >GAA (121ins2) and 457delC heterozygosity in severe congenital lung disease and surfactant protein B (SP-B) deficiency. Hum Mutat 1999;14:502-9. https://doi.org/10.1002/(SICI)1098-1004(199912)14:6<502::AID-HUMU9>3.0.CO;2-C
  86. Ballard PL, Nogee LM, Beers MF, Ballard RA, Planer BC, Polk L, et al. Partial deficiency of surfactant protein B in an infant with chronic lung disease. Pediatrics 1995;96:1046-52.
  87. Schuerman FA, Griese M, Gille JP, Brasch F, Noorduyn LA, van Kaam AH. Surfactant protein B deficiency caused by a novel mutation involving multiple exons of the SP-B gene. Eur J Med Res 2008;13:281-6.
  88. Matsumura Y, Ban N, Ueda K, Inagaki N. Characterization and classification of ATP-binding cassette transporter ABCA3 mutants in fatal surfactant deficiency. J Biol Chem 2006;281:34503-14. https://doi.org/10.1074/jbc.M600071200
  89. Johansson H, Nordling K, Weaver TE, Johansson J. The Brichos domain- containing C-terminal part of pro-surfactant protein C binds to an unfolded poly-val transmembrane segment. J Biol Chem 2006;281:21032-9. https://doi.org/10.1074/jbc.M603001200
  90. Thurm T, Kaltenborn E, Kern S, Griese M, Zarbock R. SFTPC mutations cause SP-C degradation and aggregate formation without increasing ER stress. Eur J Clin Invest 2013;43:791-800. https://doi.org/10.1111/eci.12107
  91. Jo HS. Association between respiratory disorders and candidate genes in Korean newborn infants. Neonatal Med 2013;20:311-7. https://doi.org/10.5385/nm.2013.20.3.311

Cited by

  1. Association of SCNN1A Single Nucleotide Polymorphisms with neonatal respiratory distress syndrome vol.5, pp.None, 2015, https://doi.org/10.1038/srep17317
  2. Metabolic Functions of the Lung, Disorders and Associated Pathologies vol.8, pp.10, 2016, https://doi.org/10.14740/jocmr2668w
  3. Genetic Determination of Bronchopulmonary Dysplasia Formation: Pros and Cons vol.14, pp.1, 2014, https://doi.org/10.15690/pf.v14i1.1698